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Discriminant Model for Cytologic Distinction of Large Cell
Neuroendocrine Carcinoma from Small Cell Carcinoma of
the Lung
Rira Hoshi, CT,* Noriyuki Furuta, CT,* Takeshi Horai, MD,* Yuichi Ishikawa, MD, PhD,†
Satoshi Miyata, PhD,‡ and Yukitoshi Satoh, MD, PhD*§
Background: To establish cytologic criteria for pulmonary large
cell neuroendocrine carcinoma (LCNEC), we developed and evalu-
ated a discriminant model for cytologic differential diagnosis be-
tween LCNEC and small cell lung carcinoma (SCLC).
Methods: Aspiration cytologic and/or imprint smears from 29
LCNEC cases were reviewed in comparison with 26 SCLC cases.
We selected the following parameters for assessment: background,
cellular arrangement, cell clusters, cell cohesion, arrangements, cell
dimensions areas, the presence of cytoplasm and/or prominent
nucleoli, nuclear features, mitosis, naked nuclei, and nuclear streak-
ing. To demonstrate the utility of differences in frequencies of
cytologic parameters for LCNECs and SCLCs, a discriminant model
was developed and evaluated.
Results: Among the cytologic parameters investigated, large clus-
ters (consisting of 60 tumor cells) with tight cohesion and small
tumor cells (showing 120 m2) without prominent nucleoli on
each case were particular focuses of attention, because statistically
significant differences with good power were evident between the
LCNEC and SCLC groups for their frequencies (p  0.0001). On
the basis of variation in plotted location on scatter plots, a discrimi-
nant model for LCNEC and SCLC was made and evaluated by
logistic discriminant analysis. Sensitivity, specificity, and accuracy
were all 100%. With leave-one-out cross validation, the predicted
error rate of the discriminant model for new cases was 0.00545.
Conclusion: Our model based on the cytologic features of large cell
clusters with tight cohesion and of small tumor cells without prom-
inent nucleoli should be a useful aid for distinction between LC-
NECs and SCLCs.
Key Words: Lung cancer, Large cell neuroendocrine carcinoma,
Small cell lung carcinoma, Discriminant model, Cytology.
(J Thorac Oncol. 2010;5: 472–478)
Large cell neuroendocrine carcinoma (LCNEC) of the lungand small cell lung carcinoma (SCLC) are both now
considered as high-grade neuroendocrine carcinomas arising
in the lung.1–4 Based on the large, multiinstitutional study in
Japan, Asamura et al.5 reported that the 5-year survival rates of
patients with all stages were 40.3% for LCNEC and 35.7% for
SCLC, the differenc not being statistically significant. However,
these two tumors are generally thought to have different clinical
features1,4,6–14 and require different treatments.
Currently, surgical resection is advocated for the LC-
NEC as same as other nonsmall cell lung cancers.15 However,
Iyoda et al.10 reported that patients with stage I disease treated
with either neoadjuvant or postoperative adjuvant chemother-
apy had a significantly better prognosis than their counter-
parts groups receiving surgery alone. Therefore, LCNEC
requires a refined histology-specific approach. Conversely,
the SCLC is aggressive but chemosensitive, and a standard
therapeutic strategy has already been established.5
The cytologic diagnosis of SCLC is clear, but criteria
for the LCNEC have yet to be established.5,16–22 Recently, the
cytologic features of LCNEC described in several reports are
as follows: necrotic background, loose cell aggregates, large
cell size (three times as large as mature lymphocytes), rosette
and Indian-filing arrangements, abundant cytoplasm, granular
nuclear chromatin, clear nucleoli, naked nuclei, and nuclear
streaking.17–22 Because these are also often recognized in
SCLC cases,15,16,23 they are not specific.
The aim of this study was to elucidate the cytologic
characteristics of the LCNEC in comparison with SCLCs
particularly and evaluate the utility of proposed scoring
system for their differential diagnosis.
MATERIALS AND METHODS
Patients
The pathology files of the Cancer Institute Hospital
(Tokyo, Japan) between 1990 and 2007 were searched for 29
patients who underwent pulmonary resection for LCNECs.
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These LCNEC cases were all confirmed by pathologic exam-
ination on surgically resected materials with the World
Health Organization (WHO) classification system.15 The his-
tologic diagnostic criteria of LCNEC proposed by WHO are
as follows: neuroendocrine morphologic features (organoid
nesting, palisading, rosettes, and trabecular growth pattern); a
high mitotic rate (10 per 10 high-power fields); necrosis
(often large zones); cellular features of a nonsmall cell
carcinoma (large cell size, a low nuclear/cytoplasmic ratio,
polygonal shape, finely granular eosinophilic cytoplasm,
coarse chromatin, and/or frequent nucleoli); and neuroendo-
crine features by immunohistochemistry or electron micros-
copy or both.15 For comparison, we randomly extracted 26
cases of SCLCs diagnosed during the same period, 16 of
which were diagnosed with surgical materials and the re-
maining 10 with transbronchial lung biopsy samples. The
histologic diagnosis of SCLCs was also based on the WHO
classification system.15 Combined LCNECs and SCLCs
and SCLC cases after any treatment were all excluded in
this study, which was approved by our institutional review
board, each patient giving written informed consent before
treatment.
Cytologic Materials
Cytologic specimens obtained by transbronchial aspi-
ration and/or imprint from the resected specimens were fixed
routinely in 95% ethanol and stained by the Papanicolaou
method. Five to 12 cytologic slides were reviewed for each
patient. From previous studies,17–22 we selected the following
parameters for assessment: necrotic background, cellular ar-
rangement, tumor cell clusters, tumor cell cohesion, cell
arrangements, cell dimensions areas, the presence of tumor
cells with identifiable cytoplasm and/or prominent nucleoli,
nuclear features, mitosis, naked nuclei, and nuclear streaking.
Cluster size was categorized in the three groups as follows:
small clusters, consisting of more than 10 and less than or
equal to 20 cells; intermediate-sized clusters, consisting of
more than 20 cells and less than 60 cells; and large clusters,
consisting of more than or equal to 60 cells. Tight cohesive-
ness of clusters was defined as a straight cluster border
composed of cells lined up and/or arranged in palisades. Cell
areas were measured for 50 cells extracted at random in each
specimen and calculated as (long diameter  short diameter/
2  2)2  (  3.14). The diameters of tumor cells were
measured using an ocular micrometer (DSM; Olympus, To-
kyo, Japan). Cell size was categorized in 2 groups as follows:
small tumor cells, less than or equal to 120 m2; and large
tumor cells, more than or equal to 600 m2.
Statistical Analysis
The clinicopathologic factors analyzed in this study in-
cluded age (65 or 65 years), gender, and smoking habits,
evaluated by the 2 test. Differences in cell areas and the
frequency of the cytologic features between LCNEC and SCLC
cases were analyzed by an unpaired Student t test and 2 test;
p  0.05 was considered significant.
Logistic Discriminant Analysis
To demonstrate the utility of differences in frequencies
of cytologic parameters for LCNECs and SCLCs, a discrimi-
nant model was developed and evaluated. The frequencies of
two cytologic features, in which differences were statistically
significant, were regarded as two variables for a set of data,
displayed as a scatter plot. By logistic discriminant analysis
based on the scatter plots, a discriminant model for LCNEC
and SCLC was made. When two variables for frequency of
cytologic features were regarded as x1 and x2, the probability
of an SCLC was calculated as follows.
PSCLC 
exp(319.8110.82x116.30x2)
1 exp(319.8110.82x1 16.30x2)
And the discriminant line was as follows.
319.8110.82x1 16.30x2 0N x2
 19.62 0.6641x1
We regarded a point on upper part of the line as true (SCLCs)
and a point on lower part of the line as false (LCNECs).
Furthermore, we analyzed prediction of error discrimination
for new cases by leave-one-out cross validation. A discrimi-
nant model for LCNEC and SCLC was made except in one
case. The excepted case was predicted by the discriminant
model, and the discrimination confirmed whether it was
correct. For all SCLC and LCNEC cases, the same analyses
were performed repeatedly.
RESULTS
Clinical Findings
Clinicopathologic findings for the 29 LCNEC patients
are summarized in Table 1. There were 26 men and 3 women,
ranging in age from 48 to 80 years, with a median of 67 years.
Lobectomy was performed on all. Mean follow-up time was
2.4 years (range, 0.33–9 years); 14 were dead, and 15 were
alive at the time of this analysis. All patients had a smoking
habit, ranging from 3 to 206.5 pack years. Of the 26 SCLC
patients, 19 were men and 7 women, ranging in age from 58
to 80 years, with a median of 69 years. Eight were treated
with surgical resection and eight with surgical resection after
chemotherapy. In these 16 cases, no combination of SCLC
with other histologic types was identified on resected mate-
rials. The remaining 10 underwent chemotherapy and/or
radiotherapy, but again no admixture of other types was noted
in biopsy specimens. Mean follow-up for the 26 patients was
2.6 years (range, 0.08–8 years); 14 were dead, and 12 were
alive at the time of this analysis. All patients also had a
smoking habit. A comparison of data for LCNEC and SCLC
groups revealed no statistically significant differences in age,
gender, and smoking status (Table 1).
Cytologic Findings
The initial cytologic diagnoses of 29 LCNEC patients
were 4 LCNECs, 5 SCLCs, 2 combined SCLCs and adeno-
carcinomas, 5 neuroendocrine carcinomas, 1 atypical carci-
noid, 7 poorly differentiated adenocarcinomas, 3 poorly dif-
ferentiated squamous cell carcinomas, and 2 nonsmall cell
carcinomas. In the LCNEC group, the unanimity in diagnosis
between pathology and cytology was 21.1%. The cytologic
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diagnoses for the 26 SCLC patients were all SCLCs, with
statistically significant unanimity (p  0.0001).
In a preliminary study, we evaluated any cytologic
differences between aspiration smears and touch preparations
in pilot groups consisting of 10 cases each of LCNEC and
SCLC. In these groups, aspiration preparations and imprints
showed no significant differences in any of the parameters
chosen for assessment (data not shown). Comparisons be-
tween LCNEC and SCLC for each cytologic parameter are
shown in Table 2. Cytologic parameters with statistically
significant differences were as follows: cellular arrangement,
presence of large clusters, tumor cell cohesion, palisading
arrangement of tumor cells, mean of cellular areas, and
presence of small cells without prominent nucleoli and naked
nuclei. With regard to cellular arrangement, single cells were
evident in all SCLC cases, whereas tumor cell clusters were
frequently observed in LCNECs (Figures 1, 2). In the
LCNEC group, although single cells were evident, many of
them had naked nuclei. In particular, large clusters consisting
of more than 60 cells were characteristic in LCNEC group
TABLE 2 Cytologic Comparison Between LCNEC and
SCLC
Cytologic Parameters
LCNEC
(n  29)
SCLC
(n  26) p value
Necrotic background 25/29 (86.2%) 23/26 (88.5%) 0.802
Predominant cellular
arrangement
Cluster 26/29 (89.7%) 5/26 (19.2%)
Single cells 3/29 (10.3%) 21/26 (80.7%) 0.0001
Presence of characteristic
clusters
Large sized 27/29 (93.1%) 4/26 (15.4%) 0.0001
Strong cohesion 27/29 (93.1%) 3/26 (11.5%) 0.0001
Presence of tumor cell
arrangement
Rosette 28/29 (96.6%) 21/26 (80.7%) 0.061
Molding 26/29 (89.7%) 26/26 (100 %) 0.092
Pair cells 12/29 (41.3%) 17/26 (65.4%) 0.075
Palisading 27/29 (93.1%) 3/26 (11.5%) 0.0001
Mean tumor cell size 178.1 m2 127.2 m2 0.0001
Presence of characteristic
tumor cells
Large sized 18/29 (62.0%) 20/26 (76.9%) 0.224
Evidently identifiable
cytoplasm
27/29 (93.1%) 20/26 (76.9%) 0.089
Prominent nucleoli 24/29 (82.8%) 20/26 (76.9%) 0.589
Small sized without
prominent nucleoli
15/29 (51.7%) 26/26 (100 %) 0.0001
Chromation pattern
Finely granular 10/29 (34.5%) 11/26 (42.3%)
Finely granular to
granular
14/29 (48.3%) 15/26 (57.7%) 0.085
Granular 5/29 (17.2%) 0/26 (0 %)
Presence of characteristics
Mitoses 25/29 (86.2%) 25/26 (96.2%) 0.200
Nuclear streaking 26/29 (89.7%) 25/26 (96.2%) 0.354
Naked nuclei 24/29 (82.8%) 10/26 (38.5%) 0.0007
TABLE 1. Clinicopathologic Findings for LCNEC and SCLC
Cases
Characteristic
No. of
Patients
LCNEC
(n  29)
SCLC
(n  26) p
Age (yr)
65 14 9 5 0.32
65 41 20 21
Gender
Male 45 26 19 0.11
Female 10 3 7
Smoking status
Nonsmoker 0 0 0 1.00
Smoker 55 29 26
Cytologic materials
TBAC 34 16 18 0.56
IC 5 3 2
TBAC and IC 16 10 6
Cytologic diagnosis
LCNEC 4 4 0 0.0001
LCNEC  SCLC 2 2 0
NE 4 4 0
SCLC 31 5 26
SCLC  NSCLC 2 2 0
NSCLC 12 12 0
Tumor location
Right lung 5 — 5 —
RUL 15 12 3
RLL 12 7 5
Left lung 2 — 2
LUL 14 9 5
LLL 7 1 6
Type of location
Central 11 3 8 0.09
Peripheral 44 26 18
Tumor size (cm)
3.0 25 12 13 —
3.0 24 17 7
NA 6 0 6
Pathologic stage (pTNM)
IA 14 8 6 —
IB 12 11 1
IIA 5 1 4
IIB 4 3 1
IIIA 8 4 4
IIIB 2 1 1
IV 6 1 5
NA(LD) 4 — 4
Survival after surgery
Dead 28 14 14 0.68
Alive 27 15 12
Mean 	 SD 2.39 	 2.27 2.63 	 2.33
TBAC, transbronchial aspiration cytology; IC, imprint cytology; LCNEC, large cell
neuroendocrine carcinoma; SCLC, small cell lung carcinoma; NE, neuroendocrine
carcinoma; NSLC, nonsmall cell lung carcinoma; RUL, right upper lobe; RLL, right
lower lobe; LUL, left upper lobe; LLL, left lower lobe; NA, not available; pTNM, from
Ref. 15; LD, Limited disease.
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(Figures 1, 2). Also, on those histologic specimens, cell adhesion
between tumor cells of LCNEC cases was conspicuous, whereas
it was indistinct in SCLC cases (Figures 1B, D).
Furthermore, tumor cell cohesion was weak in SCLC
cases, whereas in LCNEC cases tightly cohesive clusters
predominated (Table 2). Frequencies of large clusters with
tight cohesion are shown in Figure 3. The mean frequency
was 37.7 	 21.0% in the LCNEC cases and 4.2 	 8.4% in
SCLCs, the difference being statistically significant (p 
0.0001). LCNEC cases featured discrete cell nests divided by
fibrous stroma with frequent peripheral palisading, whereas
SCLC cases were characterized by cell nests, frequently
infiltrating adjacent fibrous stroma (Figure 1).
Mean cell areas were 178.1 	 84.8 m2 (range, 45.3–
808.9 m2) for LCNEC cases and 127.8 	 69.3 m2 (range,
36.8–699.5 m2) for SCLCs, the difference being statisti-
cally significant (p  0.0001). The distributions are shown
graphically in Figure 3. Some 58.2% of the SCLC cells
(756/1300) were less than 120 m2, as compared with only
24.6% for LCNEC cells (357/1450; p  0.0001). Further-
more, small tumor cells lacking prominent nucleoli in SCLC
cases were observed more frequently than in LCNEC cases
(p  0.0001; Table 2 and Figure 5). Frequencies are shown
in Figure 4. The mean values were 11.9 	 12.1% in LCNEC
and 55.8 	 18.9% in SCLC cases, the difference being
FIGURE 1. Photomicrographs illus-
trating cellular arrangement in
transbronchial aspiration or histol-
ogy specimens of LCNEC and SCLC
cases. A, Large and three-dimen-
sional clusters are conspicuous in a
cytologic smear of an LCNEC case
(Papanicolaou stain, 20); B, tumor
nests of an LCNEC case show pali-
sading and Rosette-like formations
in a histology specimen (hematoxy-
lin and eosin stain, 40); C, single
cells are conspicuous in the cyto-
logic smear of an SCLC case (Papa-
nicolaou stain, 20); and D, tumor
cells of an SCLC case comprise ir-
regular nests in a histology speci-
men (hematoxylin and eosin stain,
40).
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FIGURE 2. Frequencies of large clusters with tight cohesion
in the LCNEC and SCLC groups (n  55).
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FIGURE 3. Histograms of cell areas in LCNEC and SCLC
groups. Note that about 60% of the SCLC cells fall in the
range of less than 120 m2, as compared with about 25%
for LCNEC cells (p  0.0001).
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statistically significant (p  0.0001). Also, in histologic
specimens, SCLC cases had the cell nests predominantly
composed of small tumor cells with scant cytoplasm without
nucleoli, whereas LCNEC cases demonstrated cell nests pre-
dominantly composed of large tumor cells with abundant
cytoplasm and occasional prominent nucleoli (Figure 5B, D).
Logistic Discriminant Analysis
For the frequencies of large clusters with tight cohesion
and small tumor cells without prominent nucleoli, statistically
significant differences with strong power was evident be-
tween LCNEC and SCLC groups. Therefore, these two cy-
tologic parameters were considered as the two variables for
the scatter plots. The dots for LCNEC cases are located on
the lower right, whereas those of SCLC cases were located
on the upper left, with clear differences between the two
for the majority. The results of logistic discriminant analysis
are shown in Figure 6. Because all SCLC and LCNEC cases
were cytologically discriminated accurately, sensitivity, spec-
ificity, and accuracy were all 100%. Moreover, the results of
leave-one-out cross validation, shown in Figure 7, gave a
predicted error rate of (2  1)/55  0.00545.
DISCUSSION
In this study, the large cell cluster with tight cohesion
was confirmed to be a valuable cytologic feature, allowing
distinction between LCNECs and SCLCs. Although other
reports on cytologic features of LCNECs described that cell
cohesion of LCNECs was reduced as in SCLC,17–22 the
difference was highly significant in our series. However,
palisade arrangement was described as a one point for cyto-
logic distinction of LCNEC from SCLC,17–22 and it was
considered to be easy to detect tight cell cohesion by light
microscope. Therefore, it should be emphasized that focusing
on large clusters with tight cohesion is most important for
cytologic discrimination between LCNECs and SCLCs.
Several authors showed that tumor cells of LCNECs
had similar morphologic features to SCLCs except for cell
size, this being significantly larger for LCNECs than
SCLCs.17–22 In these series, a majority of the SCLC cells
were less than 120 m2 in size, statistically significant as
compared with LCNEC cells (p  0.0001). Another charac-
teristic was that most of small cells in SCLC cases had no
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FIGURE 4. Frequencies of small tumor cells without promi-
nent nucleoli in the LCNEC and SCLC groups (n  55).
FIGURE 5. Photomicrographs illus-
trating single cells and tissue archi-
tecture in LCNEC and SCLC cases.
A) Tumor cells 120 m2 and/or
with prominent nucleoli are evident
in a cytologic smear of an LCNEC
case (Papanicolaou stain, 100); B,
nests of LCNEC cells are predomi-
nantly composed of large tumor
cells with abundant cytoplasm and
occasional prominent nucleoli (he-
matoxylin and eosin stain, 40); C,
tumor cells 120 m2 without
prominent nucleoli are evident in a
cytologic smear of an SCLC case
(Papanicolaou stain, 100); D, nests
of SCLC cells are predominantly
composed of small tumor cells with
scant cytoplasm without nucleoli
(hematoxylin and eosin stain, 40).
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prominent nucleoli, again being significantly different from
LCNECs (p  0.0001). Moreover, although naked nuclei
appear to be a significant distinguishing attribute between the
two tumor types, it was considered to be inadequate for
inclusion in the discriminant model for the following reasons:
it is rather difficult to perceive cytoplasm in intact large cells
compared with small cells, and naked nuclei was not found in
more than 60% of SCLC cases. Therefore, only the frequency
of the small cells without prominent nucleoli contributed to
cytologic discrimination between LCNEC and SCLC.
To establish accurate cytologic diagnosis of LCNEC
using the two cytologic parameters, we established a dis-
criminant model that gave exceedingly good sensitivity, spec-
ificity, and accuracy. The current discriminant model, how-
ever, does have some problems with routine cytology as
follows: complicated procedures for obtaining the two cyto-
logic parameters and necessity of uniform diagnostic criteria
among cytopathologists. However, with greater experience of
LCNEC cases and grasp of detailed cytologic features, it
should be possible to overcome these problems.
In conclusion, our discriminant model based on the
cytologic features of large cell clusters with tight cohesion
and of small tumor cells without prominent nucleoli should
prove a useful aid for distinction between LCNECs and
SCLCs particularly. Prospective large-sized studies including
other nonsmall cell lung cancers are now required to assess
the diagnostic impact of this model with routine cytology.
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